P04.19 METABOLIC IMPACT OF ANTI-ANGIOGENIC AGENTS ON GLIOMA CELLS

BACKGROUND: The direct impact on glioma cells metabolism of drugs targeting the VEGF pathway, such as Bevacizumab (Bev) or VEGFR Tyrosine Kinase Inhibitor (TKI), is poorly known. Glioma cells not only secrete high levels of vascular endothelial growth factor (VEGF)but also express VEGF receptors (VE...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mesti, T., Savarin, P., Triba, M.N., Ocvirk, J., Banissi, C., Carpentier, A.F.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2014
Materias:
Poster Presentations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185496/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.151
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares